Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...

Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...

Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leader in AI-powered disease ...

Recognition of BioMark Leadership in Early Cancer Detection Validates Commercialization Trajectory of Multimodal Lung Cancer Screening Platform Vancouver, British Columbia–(Newsfile Corp. – December ...

Lung cancer remains the single most common etiology of cancer-related mortality globally, with most patients diagnosed at advanced stages when treatment efficacy is limited. Detecting lung cancer ...

BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

What happens when you pair honeybees and halitosis? Potentially a life-saving new method to screen for cancer, according to one study. Researchers at Michigan State University have learned that ...